favipiravir
Favipiravir treatment in non-severe COVID-19
et al Efficacy and safety of favipiravir in moderate COVID-19 pneumonia patients without oxygen therapy: a randomized, phase III clinical trial
Conclusions Adding favipiravir to the standard of care provides better outcomes for hospitalized patients with COVID-19 Pregnant, lactating women, and Favipiravir is considered to be one of the effective therapies for COVID-19 when given early in the course of the disease, due to its effects in
สล็อตm24 หน้าแรก; บทความทางวิชาการ เรื่อง Favipiravir สำหรับรักษาโรคติดเชื้อไวรัสโคโรนา 2019 Favipiravir for the treatment of Coronavirus Disease 2019 โดยวิธีปกติ Favipiravir Favipiravir is a member of the class of pyrazines that is pyrazine substituted by aminocarbonyl, hydroxy and fluoro groups at positions 2, 3 and 6
